PYC Therapeutics Limited Share Price
Stocks
PYC
AU000000PYC7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
11:40:15 28/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.250 AUD | -0.44% |
|
+8.70% | +35.95% |
| 28/08 | PYC Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07/08 | ASX Biggest Losers | MT |
| Market Cap | 221.29Cr 158.77Cr 136.81Cr 128.27Cr 117.09Cr 220.59Cr 15TCr 1.52TCr 593.77Cr 7.66TCr 596.09Cr 583.12Cr 25TCr | P/E 2027 * |
-24.4x | P/E 2028 * | -26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 163.41Cr 117.24Cr 101.03Cr 95Cr 86Cr 162.9Cr 11TCr 1.12TCr 438.48Cr 5.66TCr 440.19Cr 430.61Cr 19TCr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 16.6x |
| Free-Float |
70.64% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : PYC Therapeutics Limited
| 17/03 | Bell Potter rates PYC as Speculative Buy | AQ |
| 09/25/09 | Bell Potter rates PYC as Speculative Buy | AQ |
| 07/24/07 | PYC Therapeutics : Anti Bribery & Anti Corruption Policy | PU |
| 07/24/07 | PYC Therapeutics : Definition of Independence | PU |
| 07/24/07 | PYC Therapeutics : Continuous Disclosure Policy | PU |
| 1 day | -0.44% | ||
| 1 week | +8.70% | ||
| Current month | +32.35% | ||
| 1 month | +38.46% | ||
| 3 months | +61.87% | ||
| 6 months | +49.50% | ||
| Current year | +35.95% |
| 1 week | 2.04 |  | 2.31 |
| 1 month | 1.62 | | 2.31 |
| Current year | 1.04 | | 2.31 |
| 1 year | 0.85 | | 2.31 |
| 3 years | 0.52 | | 2.31 |
| 5 years | 0.5 | | 2.31 |
| 10 years | 0.15 | | 2.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 42 | 19/08/2020 |
Thomas Ulmer
DFI | Director of Finance/CFO | 47 | 07/07/2026 |
Jonathan Riley
LAW | General Counsel | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
BRD | Director/Board Member | 42 | 30/11/2018 |
Ian Constable
BRD | Director/Board Member | - | 22/09/2025 |
Peter Coleman
CHM | Chairman | 66 | 18/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/08/26 | Free | Chief Executive Officer | 45,98,662 | 0.4676% | ||
| 13/08/26 | Free | Chief Executive Officer | 1,04,77,965 | 1.0654% | ||
| 13/08/26 | Free | Chief Executive Officer | 77,06,503 | 0.7836% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | +8.70% | +74.42% | +287.93% | 158.77Cr | |
| -0.78% | -1.42% | +2.49% | +22.78% | 5.05TCr | |
| -6.00% | -0.75% | +442.41% | +544.39% | 4.46TCr | |
| -0.24% | +0.74% | +38.69% | +18.02% | 4.31TCr | |
| -1.55% | -2.07% | +23.08% | +81.47% | 4.17TCr | |
| -0.31% | -0.83% | +16.15% | +51.42% | 3.32TCr | |
| -1.79% | -3.24% | +27.00% | +129.56% | 1.68TCr | |
| -0.58% | -2.12% | - | - | 1.63TCr | |
| -0.88% | -0.66% | +11.60% | +27.75% | 1.46TCr | |
| -1.66% | -1.25% | +78.59% | +46.66% | 1.39TCr | |
| Average | -1.42% | -0.08% | +79.38% | +134.44% | 2.76TCr | |
| Weighted average by Cap. | -1.69% | -1.00% | +95.58% | +134.57% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10Cr 7.37Cr 6.35Cr 5.95Cr 5.43Cr 10Cr 703.99Cr 71Cr 28Cr 355.37Cr 28Cr 27Cr 1.18TCr |
| Net income | -8.58Cr -6.15Cr -5.3Cr -4.97Cr -4.54Cr -8.55Cr -587.99Cr -59Cr -23Cr -296.82Cr -23Cr -23Cr -984.19Cr | -8.73Cr -6.26Cr -5.4Cr -5.06Cr -4.62Cr -8.7Cr -598.49Cr -60Cr -23Cr -302.11Cr -24Cr -23Cr -1TCr |
| Net Debt | -58Cr -42Cr -36Cr -34Cr -31Cr -58Cr -3.97TCr -398.03Cr -155.3Cr -2TCr -155.9Cr -152.51Cr -6.64TCr | -50Cr -36Cr -31Cr -29Cr -27Cr -50Cr -3.46TCr -347.17Cr -135.45Cr -1.75TCr -135.98Cr -133.02Cr -5.79TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | A$2.250 | -0.44% | 15,48,143 |
| 27/26/27 | A$2.260 | +4.15% | 23,91,608 |
| 26/26/26 | A$2.170 | +4.33% | 13,60,907 |
| 25/26/25 | A$2.080 | -0.95% | 13,61,994 |
| 24/26/24 | A$2.100 | +1.45% | 20,19,395 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PYC Stock
Select your edition
All financial news and data tailored to specific country editions
